StockData
Amgen Inc logo

Amgen Inc (AMGN) stock

AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 17/3026% above fair value
$443.89−14.04 (-3.07%)

Close on Nov 18, 2026Market cap $239.98BP/E 25.7Yield 2.18%

Amgen market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Amgen's market cap was $253.06B on Nov 11, 2026, against $186.03B a year earlier. Over the last 5 years it ranged from $117.89B to $253.06B, with a median of $152.79B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$253.06B+43.6%
2025Dec 31, 2025$176.26B+25.8%
2024Dec 31, 2024$140.09B-9.1%
2023Dec 29, 2023$154.12B+10.0%
2022Dec 30, 2022$140.12B+10.2%
2021Dec 31, 2021$127.11B-5.3%
2020Dec 31, 2020$134.16B-7.6%
2019Dec 31, 2019$145.15B+14.9%
2018Dec 31, 2018$126.34B-0.0%
2017Dec 29, 2017$126.36B+16.0%
2016Dec 30, 2016$108.90B-11.1%
2015Dec 31, 2015$122.54B+1.1%
2014Dec 31, 2014$121.16B+40.8%
2013Dec 31, 2013$86.03B+29.9%
2012Dec 31, 2012$66.21B+10.5%
2011Dec 30, 2011$59.91B+14.6%
2010Dec 31, 2010$52.26B-9.1%
2009Dec 31, 2009$57.48B–

More Amgen figures

See a number that looks wrong?